| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 34.437 | 168.152 | 217.491 | 266.991 |
| Total Income - EUR | - | - | - | - | - | - | 34.453 | 168.161 | 218.803 | 272.926 |
| Total Expenses - EUR | - | - | - | - | - | - | 21.440 | 68.441 | 94.590 | 111.616 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 13.012 | 99.720 | 124.213 | 161.310 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 12.977 | 98.182 | 122.291 | 154.067 |
| Employees | - | - | - | - | - | - | 1 | 2 | 3 | 3 |
Check the financial reports for the company - Considine Novicare S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 21.808 | 26.211 | 129.842 | 124.980 |
| Current Assets | - | - | - | - | - | - | 22.091 | 81.097 | 74.459 | 232.899 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 139 | 0 |
| Receivables | - | - | - | - | - | - | 5.198 | 29.352 | 13.605 | 357 |
| Cash | - | - | - | - | - | - | 16.893 | 51.744 | 60.714 | 232.542 |
| Shareholders Funds | - | - | - | - | - | - | 14.998 | 100.616 | 149.058 | 302.292 |
| Social Capital | - | - | - | - | - | - | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | - | - | - | 28.997 | 6.746 | 55.285 | 55.679 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Considine Novicare S.r.l.